Your browser doesn't support javascript.
loading
Evaluation and guide for embedding opioid use disorder education in health professions' curricula.
Salvador, Julie G; Bolaños-Sacoman, Sindy L; Katzman, Joanna G; Morrison, Ann E; Fox, Lindsay E; Schneider, Jennifer S; Bhatt, Snehal R; Kincaid, Tyler W; Waldorf, V Ann.
Afiliação
  • Salvador JG; Health Sciences Center, University of New Mexico, 1 UNM, Albuquerque, NM, MSC09 5030, USA. jgsalvador@salud.unm.edu.
  • Bolaños-Sacoman SL; SBS Evaluation & Program Development Specialists, LLC, Albuquerque, NM, USA.
  • Katzman JG; Health Sciences Center, University of New Mexico, 1 UNM, Albuquerque, NM, MSC09 5030, USA.
  • Morrison AE; Health Sciences Center, University of New Mexico, 1 UNM, Albuquerque, NM, MSC09 5030, USA.
  • Fox LE; Health Sciences Center, University of New Mexico, 1 UNM, Albuquerque, NM, MSC09 5030, USA.
  • Schneider JS; Health Sciences Center, University of New Mexico, 1 UNM, Albuquerque, NM, MSC09 5030, USA.
  • Bhatt SR; Health Sciences Center, University of New Mexico, 1 UNM, Albuquerque, NM, MSC09 5030, USA.
  • Kincaid TW; Health Sciences Center, University of New Mexico, 1 UNM, Albuquerque, NM, MSC09 5030, USA.
  • Waldorf VA; Health Sciences Center, University of New Mexico, 1 UNM, Albuquerque, NM, MSC09 5030, USA.
BMC Med Educ ; 23(1): 135, 2023 Mar 01.
Article em En | MEDLINE | ID: mdl-36859298
BACKGROUND: Morbidity and mortality from Opioid Use Disorder is a health crisis in the United States. During the COVID-19 pandemic, there was a devastating increase of 38.4% in overdose deaths from the 12-month period leading up to June 2019 compared with the 12-month period leading up to May 2020, primarily driven by synthetic opioids. Buprenorphine is an effective medication for opioid use disorder but uptake is slow due in part to lack of provider knowledge, confidence, and negative attitudes/stigma toward patients with OUD. Addressing these barriers in academic training is a promising approach to building workforce able to effectively treat opioid use disorder. METHODS: Our university developed a training for pre-licensure physicians, physician assistants and psychiatric nurse practitioners that included the DATA Waiver training and a shadowing experience. Expected outcomes included improved knowledge, skills and attitudes about persons with OUD and buprenorphine treatment, plans to provide this treatment post-graduation, for pre-licensure learners to have completed all requirements to prescribe buprenorphine post-graduation, and for the training to be embedded into school's curricula. RESULTS: Results were positive overall including improved knowledge and attitudes toward persons with OUD, better understanding of the benefits of this treatment for patients, increased confidence and motivation to provide this treatment post-graduation. The training is now embedded in each program's graduation requirements. CONCLUSION: Developing a didactic and experiential training on buprenorphine treatment for opioid use disorder and embedding it into medical, physician assistant, and psychiatric nurse practitioner licensure programs can help prepare future providers to treat opioid use disorder in a range of settings. Key to replicating this program in other university settings is to engage faculty members who actively provide treatment to persons with OUD to ensure shadowing opportunities and serve as role models for learners.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Buprenorfina / COVID-19 / Transtornos Relacionados ao Uso de Opioides Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Buprenorfina / COVID-19 / Transtornos Relacionados ao Uso de Opioides Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article